Leadership

Meet Our Experienced Leadership Team

CMC Pharma’s scientists possess extensive knowledge in pharmaceutical formulation and development with years of relevant industry experience to back it up. Skilled in developing, testing, and manufacturing pharmaceutical drug products, our scientists excel in solving the most demanding technical challenges in drug product development. Our science-based approach, responsiveness, flexibility, and subject matter expertise allow us to customize your experimental requirements and better meet your project needs as a trusted and reliable CDMO pharma company.

Mike Radomsky, PhD

President & Co-founder

Mike is a pharmaceutical industry scientist and executive with nearly 30 years of experience in a broad scope of leadership, technical, regulatory, entrepreneurial, and consulting roles. His expertise results from his PhD in chemical engineering from The Johns Hopkins University and leading the formulation development, manufacturing, and commercialization activities of small molecule, peptide, and protein drugs. Mike focused his early research efforts on the development of using polymers to deliver drugs in a controlled release fashion and completed his dissertation on the use of polymers to deliver antibodies for the prevention and treatment of infectious diseases.

Mike has demonstrated success in advancing generic and innovator product pipelines from discovery to launch utilizing a wide variety of resources. By leading large and small groups of cross functional teams, he has developed a keen understanding of the unique dynamics between research, development, manufacturing, quality, clinical, and the regulatory functions required to develop and manufacture FDA regulated pharmaceutical products. He is a co-founder of CMC Pharma, and currently President of CMC Pharma serving as Principal Investigator for DoD funded and other research, development, and manufacturing programs.

Don Duwe

Lab Director

Don is a professional scientist who began his pharmaceutical career in 1995 holding several positions throughout from analytical bench chemist to leadership roles. After working in the pharmaceutical industry for over 24 years, he builds quality and integrity into products from early design and conception through commercialization. He is proficient in working with early stage to commercialized drug products; including the development, validation, and transfer of stability indicating analytical methods. He has utilized his extensive knowledge in directing and managing pharmaceutical Quality Control and Quality Assurance functions.

Don has performed analytical testing on hundreds of small molecule products from raw material to drug products for human use and participated in the execution of early to late-stage development of complex analytical methods. In Quality roles, he was an active member of committees providing direction for the development and sustainability of drug shortage finished dosage products. Don is currently the Lab Director at CMC Pharma responsible for all laboratory operations and supervision of CMC Pharma chemists.

Joey Glassco

Director of Business Development

Joey brings more than 35 years of experience across industrial and pharmaceutical markets, including 15 years supporting oral solid dose, parenteral, and drug–device combination programs.

Joey takes complex technical challenges and turn them into clear, actionable development and commercialization strategies. For our clients, that means a smoother, more thoughtful experience from early conversations through proposal development and execution, with a strong focus on aligning the right technical solutions to move programs forward efficiently.

Lisa A. Losch

Senior Project Manager

Lisa is a Chemical Engineer with 25+ years of experience in engineering, project management, and operations at manufacturing companies as well as the government and government contractors.

Her experience lies in strategizing and leading cross-functional teams to successfully execute complex projects including areas of sourcing, manufacturing, logistics, and cost control. She has exceptional attention to detail and organizational skills. Lisa is currently the Special Projects Manager at CMC Pharma.

Casey Loveland

Business Manager

Casey has a background in marketing, working primarily in publishing and insurance since graduating with a degree in Communications from the University of San Diego. She transitioned into Pharmaceuticals 8 years ago to assist in the building of CMC Pharma and now involved in the day to day operations of the company.

Casey has used her organizational and planning skills to successfully set up and maintain the required licenses, insurances and procedures in order to operate a thriving company. Casey is a co-founder and current business manager at CMC Pharma.

Jared Heimovitz

Head of Marketing & Communications

Jared leads the company’s brand positioning and communications strategy, and is the primary point of contact for public relations, publications, and advertising. With over a decade of experience in strategic marketing, he focuses on strengthening the company’s reputation, expanding market visibility, and clearly articulating its scientific and operational differentiators to industry decision makers.

In addition, Jared works closely with project managers and scientific staff throughout the execution stage of commercial programs to ensure that client needs and expectations are met and exceeded. Jared also leads the companies cybersecurity initiatives, including compliance with the Cybersecurity Maturity Model Certification (CMMC) framework.

Vice Admiral Matthew Kohler

Consultant

Matt is a retired three-star admiral with 36 years of service. Throughout his career, Matt was integral in advancing information and technology in Department of Defense business and warfighting capabilities from tactical to governance levels in highly innovative and internationally intensive environments. A career naval intelligence officer and information warfare professional, he most recently served as the deputy Department of the Navy chief information officer, director of Naval Intelligence, and deputy chief of Naval Operations for Information Warfare managing a $9B portfolio. Kohler also led the US Navy’s information warfare community of over 50,000 uniformed and civilian professionals (cyber, intelligence, IT, space, meteorology, and oceanography), and managed senior executive (admirals and senior civilian executives) career development and personnel placement.

Since retiring in 2020, Matt has been consulting and advising companies that are delivering vital capabilities in support of our national defense – he has been supporting the CMC Team since 2023.

Mary Kay Delmedico, PhD

Consultant

Mary Kay has dedicated 30 years to the biopharmaceutical industry, holding senior executive leadership roles in support of scientific, clinical, regulatory, commercial, and strategic objectives across multiple therapeutic areas. She has been an integral part of product design and development from early discovery, candidate selection, IND-enabling studies, clinical development and commercialization, and is an experienced project leader of multi-functional teams.

Mary Kay holds a B.S. from St. Edwards University and a Ph.D. in chemistry from the University of California, Berkeley. She is currently serving CMC Pharma as a consultant.

Clark March

Consultant

Clark has an MS from Virginia Commonwealth University / Medical College of Virginia and more than 30 years experience in the industry. He has extensive experience with chromatographic method development and validation of bio-analytical and content/impurity/dissolution methods, conducting projects under GLP/GMP conditions, communicating with sponsors and partners, dealing with FDA inspectors during laboratory audits, managing CROs and teaching and training junior scientists.

Clark’s current role at CMC Pharma is to provide analytical chemistry oversight to all programs to ensure compliance with FDA regulations and expectations.

Discover How We Can Help You

Connect with our experts for your pharmaceutical product development needs.